Disclosing transfers of value (ToV) to Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs)

Following the European Federation of Pharmaceutical Industries and Associations (EFPIA) AGM in June 2013, a new Disclosure Code of Transfers of Value (ToV) to healthcare professionals (HCPs) and healthcare organisations (HCOs) was adopted with a view to bringing greater transparency around industry’s financial transactions with them.


In one of the most far reaching developments in the relationship between the research based pharmaceutical industry and the medical community, these financial transactions, or ToVs, must be made public from 2016.


As a result of this, IPHA as a member of EFPIA has changed its Code of Practice. From 30th June 2016 details of how member companies of IPHA engage with and support HCPs and HCOs have been publicly disclosed. ToVs for research and development, donations and grants (including medical education and unrestricted educational grants), consultancy fees, registration fees or travel costs to attend medical conferences will be disclosed.


The first data disclosed related to 2015 and was published in a central industry report on the IPHA website on 30th June. You can access the central report here.


In order to adhere to data protection laws, HCPs must give consent for individual data to be disclosed. In the absence of this consent, the data will be published in aggregate form.



In the interest of greater transparency, IPHA has urged HCPs to grant such consent



Working together for patients (ToV education video)

ToV - your questions answered

Related Content

Brain Cells

IPHA is a member of -


For medicines and clinical trials information visit -

medicines.ieself-care.ieICTRP Portal